ID   Y-ML-1B
AC   CVCL_4779
DR   cancercelllines; CVCL_4779
DR   IARC_TP53; 17883
DR   RCB; RCB5394
DR   Wikidata; Q54995162
RX   PubMed=12377411;
RX   PubMed=38639832;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Y-ML-1B
CC   Population: Japanese.
CC   Characteristics: Expresses high levels of CSF2, CSF3, IL6 and IL8 (PubMed=12377411).
CC   Doubling time: 19 hours (PubMed=12377411).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Unspecified (PubMed=12377411).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
RX   PubMed=12377411; DOI=10.1016/S0165-4608(02)00536-8;
RA   Sekido Y., Sato M., Usami N., Shigemitsu K., Mori S., Maeda O.,
RA   Yokoi T., Hasegawa Y., Yoshioka H., Shimokata K.;
RT   "Establishment of a large cell lung cancer cell line (Y-ML-1B)
RT   producing granulocyte colony-stimulating factor.";
RL   Cancer Genet. Cytogenet. 137:33-42(2002).
//
RX   PubMed=38639832; DOI=10.1007/s13577-024-01055-0; PMCID=PMC11194210;
RA   Kasai F., Fukushima M., Miyagi Y., Nakamura Y.;
RT   "Genetic diversity among the present Japanese population: evidence
RT   from genotyping of human cell lines established in Japan.";
RL   Hum. Cell 37:944-950(2024).
//